Intravascular leiomyomatosis associated with uterine STUMP extending into the right atrium: a rare case report
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260578Keywords:
Intravascular leiomyomatosis, Smooth muscle tumour of uncertain malignant potential, Right atrial thrombus, Inferior vena cava thrombusAbstract
Intravascular leiomyomatosis (IVL) is a rare benign smooth muscle tumor that originates from the uterus and proliferates within venous channels, occasionally extending into the heart. Smooth muscle tumour of uncertain malignant potential (STUMP) represents a borderline uterine neoplasm with unpredictable biological behavior. The coexistence of IVL and STUMP is exceptionally rare, posing diagnostic and therapeutic challenges. We report the case of a 52-year-old perimenopausal woman who presented with abdominal distension and bilateral lower limb pain for six months. Imaging revealed a large uterine mass with a thrombus extending from the pelvic and gonadal veins into the inferior vena cava (IVC) and right atrium. The patient underwent staging exploratory laparotomy with total abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic tumour excision, venotomy with thrombus extraction, and lymphadenectomy. Histopathology confirmed a spindle cell neoplasm consistent with a STUMP associated with intravascular leiomyomatosis. This case highlights the rare coexistence of STUMP and IVL with intracardiac extension. Comprehensive preoperative imaging, multidisciplinary surgical planning, and complete tumor resection are crucial to prevent recurrence and ensure favorable outcomes.
References
Ha HI, Choi MC, Heo JH, Kim KA, Jung SG, Park H, et al. A clinicopathologic review and obstetric outcome of uterine smooth muscle tumor of uncertain malignant potential (STUMP) in a single institution. Eur J Obstet Gynecol Reprod Biol. 2018;228:1-5. DOI: https://doi.org/10.1016/j.ejogrb.2018.06.003
Karataşlı V, Çakır I, Ayaz D, Budak A, Sanci M. Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): a single center experience. J Gynecol Obstet Hum Reprod. 2019;48(8):637-42. DOI: https://doi.org/10.1016/j.jogoh.2019.03.003
Kempson RL. The Uterus: Sarcomas and Related Neoplasms. Washington (DC): Armed Forces Institute Pathol. 1973.
Hanby AM, Walker C, Tavassoli FA, Devilee P. Pathology and genetics: tumours of the breast and female genital organs. WHO Classification of Tumours Vol. IV. Breast Cancer Res. 2004;6:133. Available at: https://link.springer.com/article/ 10.1186/bcr788. Accessed on 18 December 2025. DOI: https://doi.org/10.1186/bcr788
Liu HT, Wong CN, Liu FS, Wong CN. Uterine smooth muscle tumor of uncertain malignant potential: a review of current knowledge. Taiwan J Obstet Gynecol. 2022;61(6):935-40. DOI: https://doi.org/10.1016/j.tjog.2022.08.003
Steinmetz OK, Bedard P, Prefontaine ME, Bourke M, Barber GG. Uterine tumor in the heart: intravenous leiomyomatosis. Surgery. 1996;119(2):226-9. DOI: https://doi.org/10.1016/S0039-6060(96)80174-7
Gwacham NI, Manyam M, Fitzsimmons CK, Kilowski KA, Varnagy D, Karas TZ, et al. Multidisciplinary approach to pelvic leiomyomatosis with intracaval and intracardiac extension: a case report and review of the literature. Gynecol Oncol Rep. 2022;40:100946. DOI: https://doi.org/10.1016/j.gore.2022.100946
Gan HL, Zhang JQ, Zhou QW, Kong QY, Zhao S, Bo P. Surgical treatment of intracardiac leiomyomatosis. J Thorac Cardiovasc Surg. 2011;142(4):823-8. DOI: https://doi.org/10.1016/j.jtcvs.2011.01.023
Ordulu Z, Chai H, Peng G, McDonald AG, De Nictolis M, Garcia-Fernandez E, et al. Molecular and clinicopathologic characterization of intravenous leiomyomatosis. Mod Pathol. 2020;33(9):1844-60. DOI: https://doi.org/10.1038/s41379-020-0546-8
Ma G, Miao Q, Liu X, Zhang C, Liu J, Zheng Y, et al. Different surgical strategies of patients with intravenous leiomyomatosis. Medicine (Baltimore). 2016;95(37):e4902. DOI: https://doi.org/10.1097/MD.0000000000004902
Marrone G, Crinò F, Morsolini M, Caruso S, Miraglia R. Multidisciplinary approach in the management of uterine intravenous leiomyomatosis with intracardiac extension: case report and review of literature. J Radiol Case Rep. 2019;13(7):1-13. DOI: https://doi.org/10.3941/jrcr.v13i7.3607
Li R, Shen Y, Sun Y, Zhang C, Yang Y, Yang J, et al. Intravenous leiomyomatosis with intracardiac extension: echocardiographic study and literature review. Tex Heart Inst J. 2014;41(5):502-6. DOI: https://doi.org/10.14503/THIJ-13-3533
Biri A, Korucuoglu U, Zumrutbas N, Tiras B, Guner H. Intravenous leiomyomatosis treated with aromatase inhibitor therapy. Int J Gynaecol Obstet. 2008;101(3):299-300. DOI: https://doi.org/10.1016/j.ijgo.2007.12.002
Umranikar S, Umranikar A, Byrne B, Moors A. Intravascular leiomyomatosis: unusual variant of leiomyoma. Gynecol Surg. 2009;6:399-402. DOI: https://doi.org/10.1007/s10397-008-0426-6
Wang C, Shao J, Ma X, Zhou Y, Ma G, Cheng N, et al. One-stage resection of intravascular leiomyomatosis involving the right heart chamber through a single laparotomy. Front Cardiovasc Med. 2022;9:976478. DOI: https://doi.org/10.3389/fcvm.2022.976478
Downloads
Published
How to Cite
Issue
Section
